Cost-effectiveness of combining AI and cfDNA with LDCT for lung cancer screening in China: a modelling study
Background: Lung cancer remains one of the leading causes of cancer-related mortality in China, where early detection through screening is critical for improving survival rates. Low-dose computed tomography (LDCT) has proven effective for early lung cancer screening, but its high false-positive rate...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2025-02-01
|
| Colección: | The Lancet Regional Health. Western Pacific |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2666606524002876 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|